CN1279995A - Chinese medicine composition for curing rhinitis - Google Patents
Chinese medicine composition for curing rhinitis Download PDFInfo
- Publication number
- CN1279995A CN1279995A CN 99109566 CN99109566A CN1279995A CN 1279995 A CN1279995 A CN 1279995A CN 99109566 CN99109566 CN 99109566 CN 99109566 A CN99109566 A CN 99109566A CN 1279995 A CN1279995 A CN 1279995A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- radix
- active component
- rhizoma chuanxiong
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine composite for treating rhinitis is prepared with Cape jasmine, Radix Scutellariae, Chinese angelica, Rhizoma Ligustici Chuanxiong, Herba Schizonepetae and other nine Chinese medicinal materials. It has obvious curative effect on nasosimusitis, adnasosimusitis, acute and chronic rhinitis, suppurative rhinitis, stuffy nose, etc. up to 98.9% and cure rate over 96.7%. It has the features of short treatment period, low side effect and low dosage.
Description
The present invention relates to a kind of Chinese medicine composition for the treatment of rhinitis, in particular for treatment sinusitis, nasal sinusitis, purulent rhinitis and acute and chronic rhinitis.
At present, the medicine of treatment rhinitis is much as BIYANKANG, clear nose ball and bidouyan mixture, bidouyan koufuye etc. both at home and abroad, though they all have certain curative effect to rhinitis, but exist that dose is big, treatment time is long and defective such as cost height, these have all brought very big financial burden to the patient, even so, these medicines can not fundamentally be treated sinusitis, nasal sinusitis, purulent rhinitis and acute and chronic rhinitis, and relapse rate is higher.
The purpose of this invention is to provide a kind of rhinitis curative effect height, short treating period and little Chinese medicine composition of side effect for the treatment of.
Chinese medicine composition of the present invention is made up of active component and pharmacy excipient, and active component wherein selects for use following raw materials according to make: Fructus Gardeniae 1-3 weight portion, Radix Scutellariae 1-3 weight portion, Radix Angelicae Sinensis 1-3 weight portion, Rhizoma Chuanxiong 1-3 weight portion, Herba Schizonepetae 1-3 weight portion, Herba Menthae 1-3 weight portion, Radix Paeoniae Alba 1-3 weight portion, Flos Carthami 1-3 weight portion, Radix Glycyrrhizae 1-3 weight portion, Cortex Moutan 1-3 weight portion, Radix Platycodonis 1-3 weight portion, Radix Saposhnikoviae 1-3 weight portion, Fructus Forsythiae 1-3 weight portion and Radix Angelicae Dahuricae 1-3 weight portion; More preferably the raw material consumption is: Fructus Gardeniae 1-2 weight portion, Radix Scutellariae 1-2 weight portion, Radix Angelicae Sinensis 1-2 weight portion, Rhizoma Chuanxiong 1-2 weight portion, Herba Schizonepetae 1-2 weight portion, Herba Menthae 1-2 weight portion, Radix Paeoniae Alba 1-2 weight portion, Flos Carthami 1-2 weight portion, Radix Glycyrrhizae 1-2 weight portion, Cortex Moutan 1-2 weight portion, Radix Platycodonis 1-2 weight portion, Radix Saposhnikoviae 1-2 weight portion, Fructus Forsythiae 1-2 weight portion and Radix Angelicae Dahuricae 1-2 weight portion; When the consumption of each raw material of selecting for use is equal portions, drug effect the best.
The preparation of present composition active component is at first to adopt Herba Schizonepetae, Herba Menthae and Rhizoma Chuanxiong steam distillation to make volatile oil, is the active component I, then, medicinal residues with Herba Schizonepetae, Herba Menthae and Rhizoma Chuanxiong add the water that soaked powder with all the other raw materials again, decoct 2-3 time down at 100 ℃, except that the time first time is 1 hour, other decocting times all are 0.5 hour, merge decocting liquid, it is 80% that adding ethanol makes it contain the alcohol amount, leaves standstill, and filters, concentrate, make the active component II.
Used pharmacy excipient is to select according to different dosage forms in the present composition.As the present composition is prepared as oral liquid, just select correctives such as sucrose etc., antiseptic such as Ethyl Hydroxybenzoate etc. for use.As the present composition is prepared into tablet, just select diluent such as starch, dextrin, lactose etc. for use, wetting agent such as ethanol, starch slurry gelatine size etc., disintegrating agent such as dry starch etc., lubricant such as magnesium stearate, Pulvis Talci etc.As the present composition is prepared into capsule, just select the gelatine capsule active component of packing into for use.
The present composition is an oral medicine, by the adjusting of human body self, changes the morbid state of rhinitis, forms circulation normally.Symptoms such as it is great to sinusitis, nasal sinusitis, acute and chronic rhinitis, purulent rhinitis and concha nasalis, nasal obstruction is obstructed, the yellow thick tears of stream all have significant curative effect.Reach 98.9% through the clinical verification effective percentage, cure rate 96.7%.Be 3 days the course of treatment of the present composition, and just can fully recover general three courses of treatment.Compare 35 day course of treatment with clear nose ball 20 days the course of treatment with bidouyan mixture, bidouyan koufuye, shorten greatly.Dose also reduces in addition.See Table 1.
Medicine | Therapeutic domain | The course of treatment | Cure rate | Remarks |
The present composition | Sinusitis, nasal sinusitis, acute and chronic rhinitis, the purulent rhinitis, the concha nasalis enlargement, it is obstructed to have a stuffy nose, flow yellow thick tears | Cure general three courses of treatment of 3 days courses of treatment | 96.7% | Taking convenience has no side effect |
Bidouyan mixture, bidouyan koufuye | The acute and chronic rhinitis sinusitis | 20 days course of treatment, two courses of treatment take effect | 90.2% | The course of treatment, long dose was big |
Clear nose ball | The nasal sinusitis nasal obstruction | Take effect general two courses of treatment of 35 days courses of treatment | 87.3% | Grow the relapse rate height course of treatment |
Embodiment 2
Except that the raw material consumption all is the 10g, all the other steps are identical with embodiment 1, make the active component I ' and II '.The oral liquid of embodiment 3 present compositions
With the active component II that makes among the embodiment 1 dissolved in distilled water with 1000ml, three kinds of volatile oil of active component I are added, and add an amount of sucrose again, make oral liquid, 10 milliliters every.The tablet of embodiment 4 present compositions
With the active component II that makes among the embodiment 2 ' drying is crushed into powder, and adds starch 50g, makes granule with ethanol, adds magnesium stearate 5g, and the tablet machine of packing into is made every tablet of tablet that contains 3g.
Claims (6)
1. Chinese medicine composition for the treatment of rhinitis, it is made up of active component and medicinal excipient, it is characterized in that active component wherein is to be made by the raw material of following consumption: Fructus Gardeniae 1-3 weight portion, Radix Scutellariae 1-3 weight portion, Radix Angelicae Sinensis 1-3 weight portion, Rhizoma Chuanxiong 1-3 weight portion, Herba Schizonepetae 1-3 weight portion, Herba Menthae 1-3 weight portion, Radix Paeoniae Alba 1-3 weight portion, Flos Carthami 1-3 weight portion, Radix Glycyrrhizae 1-3 weight portion, Cortex Moutan 1-3 weight portion, Radix Platycodonis 1-3 weight portion, Radix Saposhnikoviae 1-3 weight portion, Fructus Forsythiae 1-3 weight portion and Radix Angelicae Dahuricae 1-3 weight portion.
2. according to the described Chinese medicine composition of claim 1, it is characterized in that active component is to be made by the raw material of following consumption: Fructus Gardeniae 1-2 weight portion, Radix Scutellariae 1-2 weight portion, Radix Angelicae Sinensis 1-2 weight portion, Rhizoma Chuanxiong 1-2 weight portion, Herba Schizonepetae 1-2 weight portion, Herba Menthae 1-2 weight portion, Radix Paeoniae Alba 1-2 weight portion, Flos Carthami 1-2 weight portion, Radix Glycyrrhizae 1-2 weight portion, Cortex Moutan 1-2 weight portion, Radix Platycodonis 1-2 weight portion, Radix Saposhnikoviae 1-2 weight portion, Fructus Forsythiae 1-2 weight portion and Radix Angelicae Dahuricae 1-2 weight portion.
3. according to the described Chinese medicine composition of claim 2, it is characterized in that preparing the active component raw material consumption is equal portions.
4. preparation method for the treatment of the Chinese medicine composition of rhinitis, it is made up of the following step: the raw material that a) takes by weighing following consumption: Fructus Gardeniae 1-3 weight portion, Radix Scutellariae 1-3 weight portion, Radix Angelicae Sinensis 1-3 weight portion, Rhizoma Chuanxiong 1-3 weight portion, Herba Schizonepetae 1-3 weight portion, Herba Menthae 1-3 weight portion, Radix Paeoniae Alba 1-3 weight portion, Flos Carthami 1-3 weight portion, Radix Glycyrrhizae 1-3 weight portion, Cortex Moutan 1-3 weight portion, Radix Platycodonis 1-3 weight portion, Radix Saposhnikoviae 1-3 weight portion, Fructus Forsythiae 1-3 weight portion and Radix Angelicae Dahuricae 1-3 weight portion, and standby; B) with Herba Schizonepetae, Herba Menthae and Rhizoma Chuanxiong respectively vapor distillation obtain separately volatile oil, for the active component I, standby; C) medicinal residues with Herba Schizonepetae, Herba Menthae and Rhizoma Chuanxiong add the water that soaked powder with all the other raw medicinal materials, decoct 2-3 time down at 100 ℃, 1 hour for the first time, for the second time and/or all be 30 minutes for the third time, merges three times decoction liquor, adding ethanol, to make it contain that alcohol measures be 80%, leave standstill, filter, concentrate, make the active component II; D) three kinds of volatile oil with the active component I are sprinkled upon on the active component II, make various dosage forms with an amount of pharmacy excipient.
5. according to the described preparation method of claim 4, wherein the raw material consumption is: Fructus Gardeniae 1-2 weight portion, Radix Scutellariae 1-2 weight portion, Radix Angelicae Sinensis 1-2 weight portion, Rhizoma Chuanxiong 1-2 weight portion, Herba Schizonepetae 1-2 weight portion, Herba Menthae 1-2 weight portion, Radix Paeoniae Alba 1-2 weight portion, Flos Carthami 1-2 weight portion, Radix Glycyrrhizae 1-2 weight portion, Cortex Moutan 1-2 weight portion, Radix Platycodonis 1-2 weight portion, Radix Saposhnikoviae 1-2 weight portion, Fructus Forsythiae 1-2 weight portion and Radix Angelicae Dahuricae 1-2 weight portion.
6. according to the described preparation method of claim 5, wherein each raw material consumption is equal portions.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 99109566 CN1279995A (en) | 1999-07-09 | 1999-07-09 | Chinese medicine composition for curing rhinitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 99109566 CN1279995A (en) | 1999-07-09 | 1999-07-09 | Chinese medicine composition for curing rhinitis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1279995A true CN1279995A (en) | 2001-01-17 |
Family
ID=5273982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 99109566 Pending CN1279995A (en) | 1999-07-09 | 1999-07-09 | Chinese medicine composition for curing rhinitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1279995A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101332268B (en) * | 2007-06-29 | 2012-01-25 | 郑书信 | Medicine for treating rhinitis, sinusitis |
CN102600285A (en) * | 2011-12-22 | 2012-07-25 | 青岛绿曼生物工程有限公司 | Complex propolis composition for treating infectious atrophic rhinitis of pigs and preparation method thereof |
CN103638186A (en) * | 2013-12-05 | 2014-03-19 | 青岛中科菲力工程技术研发有限公司 | Nasosinusitis-relieving traditional Chinese medicine syrup and preparation method thereof |
CN103656097A (en) * | 2013-09-25 | 2014-03-26 | 李增伟 | Traditional Chinese medicine for treating allergic rhinitis and preparation method thereof |
CN110664899A (en) * | 2019-10-24 | 2020-01-10 | 吴成章 | A Chinese medicinal composition for treating rhinitis, and its preparation method |
-
1999
- 1999-07-09 CN CN 99109566 patent/CN1279995A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101332268B (en) * | 2007-06-29 | 2012-01-25 | 郑书信 | Medicine for treating rhinitis, sinusitis |
CN102600285A (en) * | 2011-12-22 | 2012-07-25 | 青岛绿曼生物工程有限公司 | Complex propolis composition for treating infectious atrophic rhinitis of pigs and preparation method thereof |
CN103656097A (en) * | 2013-09-25 | 2014-03-26 | 李增伟 | Traditional Chinese medicine for treating allergic rhinitis and preparation method thereof |
CN103638186A (en) * | 2013-12-05 | 2014-03-19 | 青岛中科菲力工程技术研发有限公司 | Nasosinusitis-relieving traditional Chinese medicine syrup and preparation method thereof |
CN110664899A (en) * | 2019-10-24 | 2020-01-10 | 吴成章 | A Chinese medicinal composition for treating rhinitis, and its preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101147788A (en) | Medicine for treating cold and upper respiratory tract infection and its lung inflammation | |
CN1679913A (en) | Gynecologic rehabilitation capsules for treating gynecopathy | |
WO2012136110A1 (en) | Pharmaceutical formulation for treating allergic rhinitis and preparation method thereof | |
CN114558074A (en) | Traditional Chinese medicine composition for treating metabolic-related fatty liver disease and preparation method and application thereof | |
CN103316192B (en) | Traditional Chinese medicine foot-bathing liquid for treating lumbocrural pain and preparation method thereof | |
CN101129636A (en) | Medicine for treating nasal inflammation | |
CN101366903B (en) | Traditional Chinese medicine composition for treating climacteric syndrome | |
CN104524159A (en) | Pharmaceutical composition for treating hyperplasia of mammary glands | |
CN101612226B (en) | Chinese medicinal preparation for treating cold | |
CN1279995A (en) | Chinese medicine composition for curing rhinitis | |
CN103341013B (en) | A kind of Chinese medicine for the treatment of lumbago and skelalgia | |
CN1056064C (en) | Medicine for curing liver cancer and its making method | |
CN1041495C (en) | External application medicine for curing hepatic disease | |
CN102784311B (en) | Traditional Chinese medicine composition for curing women's puerperal diseases and preparation method of traditional Chinese medicine composition | |
CN105963450A (en) | Traditional Chinese medicine composition for treating dizziness and faintness | |
CN101278982A (en) | Chinese medicine compound preparation for curing acute or chronic hepatitis B and method of preparing the same | |
CN101167994A (en) | Traditional Chinese medicinal composition for treating infantile chronic nephritis | |
CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
CN106389824A (en) | Traditional Chinese medicine granules for promoting dispersing function of lung and preparation method thereof | |
CN101352496A (en) | Traditional Chinese medicine for treating hepatitis | |
CN101450133A (en) | Medicine for treating abdominopelvic cavity disease postoperative intestinal adhesion | |
CN1162163C (en) | Chinese herbal medicinal liquor for curing rheumatic arthritis | |
CN106138718A (en) | A kind of preparation method treating enteritis Chinese medicine | |
CN118806834A (en) | Traditional Chinese medicine formula for treating sensitive cough and asthma | |
CN105343688A (en) | Medicine composition for treating myocardial infarction and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |